ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|contact@chemabout.com

Insights

Chemical Industry Insights by ChemAbout

Analysis that starts from specific chemicals and raw materials — grounded in published literature, company announcements, regulatory documents, and industry data — unpacking the science, manufacturing, and compliance behind them, alongside chemical regulations, materials technology, company moves, and supply-chain risks. Fact-based industry observation and judgment.

Latest articles

Continue through the broader archive covering procurement, compliance, supplier evaluation, and product workflow topics.

Page 2

Why Doesn't the Chemical Industry Actually Sell Molecules?
ArticleJul 25, 2026

Why Doesn't the Chemical Industry Actually Sell Molecules?

A synthesis route becomes public the moment its patent expires — but most of what actually decides whether a molecule can be made reliably, safely, and cheaply never gets written down. Four layers trace the gap between a public route and a defensible manufacturing capability: process development, scale-up, accumulated tacit experience, and where AI does and doesn't fit.

Read article
Why Are High-Performance Polymers Replacing Metal?
ArticleJul 23, 2026

Why Are High-Performance Polymers Replacing Metal?

The modern materials revolution isn't a search for the best material — it's a search for one with no weak dimension. From molecular design to aerospace, AI, and clean energy, this piece traces why metal is losing ground, and why only a handful of companies can actually manufacture the polymers taking its place.

Read article
Why Can Only a Handful of Companies Make Top-Tier OLED Emitter Materials?
ArticleJul 23, 2026

Why Can Only a Handful of Companies Make Top-Tier OLED Emitter Materials?

The hardest part of making OLED was never getting a molecule to glow — it's controlling electrons: where electrons and holes go, where excitons form, and how to keep that from running wild over tens of thousands of hours. This piece walks through seven barriers to answer why so few companies can pull it off.

Read article
What's Hardest to Get After a Patent Expires Isn't the Patent — It's the Intermediate
ArticleJul 22, 2026

What's Hardest to Get After a Patent Expires Isn't the Patent — It's the Intermediate

Cyantraniliprole, pinoxaden, and sulfoxaflor all lose patent protection between 2026 and 2027. The common assumption is that any manufacturer with capacity can now copy the molecule. What usually decides whether that actually happens is whether the key intermediates are available at all.

Read article
Why the AI Boom Is Also a Chemistry Boom: Inside the Ultra-High-Purity Electronic Chemicals Supply Chain Behind HBM, CoWoS, and Electronic-Grade HF
ArticleJul 21, 2026

Why the AI Boom Is Also a Chemistry Boom: Inside the Ultra-High-Purity Electronic Chemicals Supply Chain Behind HBM, CoWoS, and Electronic-Grade HF

An AI chip isn't just bigger than an ordinary chip — it passes through more lithography, etch, clean, and polish cycles, each consuming ultra-high-purity photoresist, CMP slurry, electronic-grade HF, sulfuric acid, and PGMEA at parts-per-trillion purity. A fact-based map of why this supply chain is short, hard to switch suppliers on, and now visibly tightening.

Read article
Why Is Suzuki Coupling Still the Core Platform Reaction for Modern API Synthesis, Four Decades Later?
ArticleJul 21, 2026

Why Is Suzuki Coupling Still the Core Platform Reaction for Modern API Synthesis, Four Decades Later?

Suzuki-Miyaura coupling has quietly become the default platform reaction in small-molecule API manufacturing, shaping which building blocks get sourced and whether a route can scale to metric tons. A fact-based look at why one reaction, from Losartan to Sotorasib, still anchors modern pharmaceutical supply chains four decades after its discovery.

Read article
Why Does One Chemical Intermediate End Up in Dozens of Pesticides? Inside the Reaction Interface Economy
ArticleJul 21, 2026

Why Does One Chemical Intermediate End Up in Dozens of Pesticides? Inside the Reaction Interface Economy

A single pyridine intermediate feeds four different neonicotinoid insecticides. A single pyrazole acid feeds a whole family of SDHI fungicides. This isn't coincidence — it's the Reaction Interface Economy, the organizing logic behind modern agrochemical R&D and its supply chain.

Read article
Why Fluorine Chemistry Has Become a Foundation of Modern Industry: From PFAS Regulation to Next-Generation Drugs and Semiconductor Materials
ArticleJul 15, 2026

Why Fluorine Chemistry Has Become a Foundation of Modern Industry: From PFAS Regulation to Next-Generation Drugs and Semiconductor Materials

Fluorine is not an ordinary element but a tuning knob for molecular performance - one element that underpins drugs, agrochemicals, semiconductors, and batteries at once. This deep dive traces the C-F bond's performance leverage, why fluorine dominates modern drug design, why NF3/CF4/SF6 are irreplaceable in chip etching, the fluorite-to-HF value chain that four industries share, and why regulating PFAS (a structural, not toxicological, definition) is not the same as opposing fluorine chemistry. Every key fact cited to a primary source. Not compliance advice.

Read article
Why Can a Molecule of Just ~31 Amino Acids Reshape Modern Pharma? Reading the Next Blockbuster Through the Chemical Design of Semaglutide
ArticleJul 15, 2026

Why Can a Molecule of Just ~31 Amino Acids Reshape Modern Pharma? Reading the Next Blockbuster Through the Chemical Design of Semaglutide

GLP-1 began as one incretin hormone in a physiology textbook; today nearly every major pharma runs a GLP-1 program. Reading the industry through the chemistry of semaglutide: why native GLP-1 (~2-minute half-life) is undruggable, how an Aib substitution + a C18 albumin-binding fatty chain turned it into a once-weekly drug, why ~31 amino acids sits near the edge of SPPS, and why the real moat is process + qualification + supply chain, not the formula. Every key number cited to a primary source. Not medical advice.

Read article
CRO vs CMO vs CDMO: What's the Difference? A Guide to the Pharma Outsourcing Value Chain
ComparisonJul 14, 2026

CRO vs CMO vs CDMO: What's the Difference? A Guide to the Pharma Outsourcing Value Chain

CRO, CMO and CDMO differ by a letter or two but sit at completely different points on the drug value chain, carry different regulatory responsibility, and run on different business models. A fact-based map of the boundaries, the overlap, and the CRDMO trend now stitching them back together.

Read article
Why Can Only a Handful of Companies Make Advanced Photoresist? A Deep Dive from Photochemistry to Semiconductor Supply Chains
ArticleJul 13, 2026

Why Can Only a Handful of Companies Make Advanced Photoresist? A Deep Dive from Photochemistry to Semiconductor Supply Chains

Photoresist is a translator: it converts optical information into chemical information, then a physical pattern, then an electronic device. Every reduction in exposure wavelength - g-line to i-line to KrF to ArF to EUV - has forced this translator to rewrite itself, from the invention of chemical amplification at IBM in 1982 to today's photon-shot-noise limits at EUV. This deep dive traces the chemistry, the 2019 Japan-Korea export control episode, and why the real moat is process, qualification, data and time - not the formula.

Read article
Can Potassium Ferrate Replace Chlorine and PAC? Mechanism, Cost and Regulatory Status of a Dual-Function Oxidant
ArticleJul 13, 2026

Can Potassium Ferrate Replace Chlorine and PAC? Mechanism, Cost and Regulatory Status of a Dual-Function Oxidant

Potassium ferrate is marketed as a single chemical that does what chlorine and PAC do in two steps - oxidize, then coagulate. This article explains the redox mechanism behind that dual function, why stable solid ferrate is expensive to manufacture, how its regulatory status for drinking water is evaluated product-by-product (including China's GB/T 17218 permit regime), and why it hasn't replaced chlorine and PAC at most plants. Peer-reviewed sources throughout.

Read article
Previous
Page 2
Next